scispace - formally typeset
Journal ArticleDOI

Mechanisms of acute and chronic intestinal inflammation induced by indomethacin

TLDR
It is concluded that a single injection of Indo produces acute intestinal mucosal injury and inflammation that resolve completely within three to seven days, whereas two daily injections of Indo produce both acute and chronic Injury and inflammation.
Abstract: 
The objective of this study was to characterize the mechanisms of acute and chronic intestinal mucosal injury and inflammation induced by subcutaneously injected indomethacin (Indo). One injection of Indo (7.5 mg/kg) produced acute injury and inflammation in the distal jejunum and proximal ileum that were maximal at three days and completely resolved within one week. Two daily subcutaneous injections of Indo produced a more extensive and chronic inflammation that lasted in an active form in more than 75% of the rats for at least two weeks. Epithelial injury, as measured by enhanced mucosal permeability, was significantly elevated only at one day in the acute model (one injection) but was persistently elevated in the chronic model (two injections). Bile duct ligation completely attenuated increased mucosal permeability in the acute model, however, depletion of circulating neutrophils had no effect. Neither Indo (0-0.1 mg/ml) nor normal bile was cytotoxic to cultured rat intestinal epithelial cells; however, they synergistically promoted significant cytotoxicity. Bile collected from rats treated with Indo was cytotoxic towards the epithelial cells in a dose-dependent manner. Sulfasalazine and metronidazole (100 mg/kg/day, both) attenuated enhanced mucosal permeability in the chronic model. Massive bacterial translocation into the mesenteric lymph nodes, liver, and spleen following two injections of Indo was significantly attenuated by metronidazole. We conclude that: (1) a single injection of Indo produces acute intestinal mucosal injury and inflammation that resolve completely within three to seven days, whereas two daily injections of Indo produce both acute and chronic injury and inflammation, (2) enterohepatic circulation of Indo is important in promoting the acute phases of injury and inflammation, (3) circulating neutrophils do not play a role in the pathogenesis of this model, and (4) endogenous bacteria play an important role in exacerbating and/or perpetuating the chronic phases of injury and inflammation.

read more

Citations
More filters
Journal ArticleDOI

Microbial Influences in Inflammatory Bowel Diseases

TL;DR: Altered microbial composition and function in inflammatory bowel diseases result in increased immune stimulation, epithelial dysfunction, or enhanced mucosal permeability, which should lead to selective targeted interventions that correct underlying abnormalities and induce sustained and predictable therapeutic responses.
Journal ArticleDOI

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

TL;DR: Current clinical trials do not fulfill evidence-based criteria for using these agents in inflammatory bowel diseases (IBD), but multiple nonrigorous studies and widespread clinical experience suggest that metronidazole and/or ciprofloxacin can treat Crohn's colitis and ileocolitis, whereas selected probiotic preparations prevent relapse of quiescent ulcerativecolitis and relapsing pouchitis.
References
More filters
Journal ArticleDOI

Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process

TL;DR: An important role for neutrophils in the pathogenesis of NSAID-induced gastric ulceration is suggested and may be important in the vascular injury that occurs early after administration of these compounds.
Journal ArticleDOI

Double blind, placebo controlled trial of metronidazole in Crohn's disease.

TL;DR: Preliminary analysis suggests that metronidazole was more effective in patients with disease confined to the large intestine or affecting both small and large bowel than in those with small bowel disease only.
Journal ArticleDOI

Temporal Relationship Between Cyclooxygenase Inhibition, as Measured by Prostacyclin Biosynthesis, and the Gastrointestinal Damage Induced by Indomethacin in the Rat

Brendan J.R. Whittle
- 01 Jan 1981 - 
TL;DR: Investigation of inhibition of cyclooxygenase in the rat small intestine and gastric mucosa after subcutaneous administration of indomethacin found no temporal relationship between prostaglandin inhibition and the formation of lesions in the small intestine since the lesions became macroscopically apparent and developed at a time when cyclo oxygengenase inhibition was already declining.
Journal ArticleDOI

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

TL;DR: It appears that nonsteroidal antiinflammatory drugs cause small intestinal inflammation in two-thirds of patients on long-term treatment and on discontinuation, the inflammation may persist for up to 16 mo.
Journal Article

Studies on the absorption, distribution and excretion of indomethacin in various species

TL;DR: Indomethacin is promptly and completely absorbed after oral administration, and the half-life of the drug in plasma varies among species, ranging from 20 min to 4 hr, and most of the dose is eliminated from the body in 24 hr, the route of excretion varying among species.
Related Papers (5)